Farminveste, S.G.P.S., S.A. risk profile
41 Elevated one input has moved against it
Measured 21 October 2026 from MLFMV's filed statements. Recomputed nightly.
41 (Elevated), driven by Leverage and coverage at 63, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 47 | Elevated | Stable | Average daily turnover — $2.9K |
| Operating pressure | 41 | Elevated | Worsening | Costs outgrowing revenue — +0.1 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 63 | Stretched | Easing | Net debt to EBITDA — 4.88x |
| Competitive position | 33 | Normal | Stable | Revenue-growth gap against peers — -10.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Farminveste, S.G.P.S., S.A.